Headlands Research

Home
United States
Lake Worth, FL
Headlands Research

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Headlands Research, Healthcare administrator, Lake Worth, FL.

02/11/2026

Headlands Research is heading to New Orleans for the 6th Annual Psychedelic Therapeutics and Drug Development Conference, February 26–27!

We’re proud to be part of the progress toward regulatory approval for next-generation therapies. Set up a time to chat with Tori Wallenburg, our Director of Business Development, about how the Headlands Research network can support your upcoming research through large-volume recruitment, diverse and inclusive participant populations, and deep therapeutic expertise.

https://headlandsresearch.com/events/the-6th-annual-psychedelic-therapeutics-and-drug-development-conference/

02/09/2026

We’re pleased to highlight Dr. Mallory Myers, Principal Investigator at Okanagan Clinical Trials, a Headlands Research site.

Dr. Myers is a board-certified family physician (CCFP, LMCC) with over a decade of experience spanning comprehensive primary care and clinical research. She has contributed to Phase II–III and non-interventional studies across a broad range of therapeutic areas, including migraine, vaccines, COPD, cardiovascular risk, diabetic neuropathy, and Alzheimer’s disease.

Dr. Myers’ dual role as a frontline clinician and investigator allows her to bring real-world insight to clinical trials, ensuring research is grounded in the needs and experiences of patients. We’re proud to have her as part of the Headlands network.

02/05/2026

This National Patient Recognition Week , we’re celebrating the patients who make clinical research possible. Every study participant brings courage, commitment, and a willingness to help advance medical innovation, not just for themselves, but for future generations.

From all of us at Headlands Research, thank you to the patients who partner with us to move science forward.

02/03/2026

We’re proud to highlight Dr. Linda Pao, Medical Director and Principal Investigator at JEM Research Institute, part of the Headlands Research network!

For almost 30 years, Dr. Pao has been committed to empowering patients and communities through education. She is a frequent speaker, lecturer, and on-air medical expert, and champions greater inclusion and diversity in clinical trials. At JEM, she leads studies that drive innovation in neurological care.

Dr. Pao has worked across private practice, academic medicine, and clinical research in South Florida, specializing in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, and Lewy body dementia. Her leadership has shaped multiple programs, including serving as the founding director of the Acute Stroke Program at Jupiter Medical Center, co-director of the MDA Clinic in West Palm Beach, and a member of several hospital boards and medical committees.

We are honored to have Dr. Pao’s expertise, leadership, and patient-centered commitment within the Headlands Research network!

01/29/2026

We are pleased to highlight Dr. Mark A. Goldstein, Founder, former President and Medical Director, and current Principal Investigator and Senior Advisor, Neuroscience at JEM Research Institute, a Headlands Research site.

Dr. Goldstein began working in clinical research in the late 1990s and has since participated in more than 175 clinical trials, serving as Principal Investigator in over 125 of them. As a founding member and CEO of JEM Research Institute, he has guided the site’s growth into a leading center for clinical trials, with a focus on progressive cognitive decline and other neurological conditions.

He is a Certified Principal Investigator (CPI), board-certified in both internal medicine and neurology, and is currently a Fellow of the Academy of Physicians in Clinical Research (FAPCR), as well as a Fellow of the American Academy of Neurology (FAAN). He has held several leadership roles in health systems across Palm Beach County.

01/27/2026

We’re looking forward to attending SCOPE and connecting with others who are advancing clinical research! Through our global network of sites, experienced investigators, and diverse patient populations, we work every day to make clinical research more accessible to all.

Reach out to a Headlands Research team member to schedule a meeting and learn how we can support your upcoming research:

• Lauren Chazal, Chief Business Development Officer
• McKenzie Lang, Director of Business Development
• Ken Northrop, Site Director at Headlands Research Orlando

https://headlandsresearch.com/events/scope-2026/

01/23/2026

We’re pleased to highlight Dr. Eric Chavez, Principal Investigator at the Artemis Institute for Clinical Research, part of the Headlands Research network of sites.

Dr. Chavez completed his undergraduate degree at Harvard University and earned his medical degree from the Uniformed Services University of the Health Sciences. After serving in the US Navy, he went on to complete his psychiatry residency at UC San Diego and later earned a Master of Science in Medical Informatics from Northwestern University.

Since joining Artemis in 2014, Dr. Chavez has led and supported clinical trials across a wide range of therapeutic areas, including addiction disorders, depression, bipolar disorder, anxiety, schizophrenia, and attention deficit disorder. His work combines deep clinical expertise with a strong foundation in medical informatics, allowing him to bring a data-driven, patient-centered approach to psychiatric research.

We’re proud to have Dr. Chavez’s leadership and commitment to advancing mental health research within the Headlands Research network.

01/21/2026

Headlands Research is heading to SCOPE this February!

As a multinational, integrated clinical trial site organization, we’re proud to be part of the conversations shaping the future of clinical research. With experience supporting over 5,000 clinical trials, our focus remains the same: delivering meaningful participant experiences and the highest quality data.

If you’ll be at SCOPE, we’d love to connect. Reach out to a team member to schedule a time to chat at the event:

• Kyle Burtnett, Chief Executive Officer
• Lauren Chazal, Chief Business Development Officer
• McKenzie Lang, Director of Business Development
• Ken Northrop, Site Director at Headlands Research Orlando

https://headlandsresearch.com/events/scope-2026/

01/19/2026

As we honor Dr. Martin Luther King Jr., we recommit to building stronger, healthier communities.

At Headlands Research, we believe everyone deserves the opportunity to participate in, and benefit from, clinical research. Today reminds us to continue this work with empathy, respect, and purpose.

01/16/2026

We’re honored to see our team at Summit Research featured on Good Day Oregon (KPTV) for an important conversation on cognitive health.

In this segment, Dr. Scott Losk, Principal Investigator at Summit, breaks down:

• The difference between normal cognitive aging and dementia
• How Alzheimer’s disease fits within the broader definition of dementia
• New advances in blood-based testing that may identify Alzheimer’s earlier than ever before
• Promising progress in treatments that target the underlying biology of the disease

These innovations represent meaningful steps forward for patients, families, and caregivers, and reinforce the critical role clinical research plays in advancing care.

For information on no-cost memory screenings in the Portland area, visit summitresearchnetwork.com, or call the office at 503-228-2273

01/13/2026

We’re pleased to highlight Dr. Scott Losk, Principal Investigator at Summit Research, part of the Headlands Research network.

Dr. Losk has served as Principal Investigator for 90 clinical trials focused on Alzheimer’s disease and other dementias, contributing to research on every FDA-approved Alzheimer’s therapy currently available. He has also been a sub-investigator in more than 125 trials across a wide range of central nervous system conditions, including depression, anxiety disorders, ADHD, bipolar disorder, schizophrenia, migraine, and fibromyalgia.

Deeply involved in the Alzheimer’s community, Dr. Losk regularly provides education and presentations to caregivers, clinicians, and community groups. His extensive expertise and long-standing industry relationships give him unique access to the latest research opportunities in cognitive disorders.

We are proud to have Dr. Losk’s leadership and decades of insight driving progress in neuroscience research across the Headlands Research network.

01/07/2026

Alzheimer’s disease and other dementias remain one of the most complex challenges in medicine, but meaningful progress is underway.

In our latest blog post, Dr. Scott Losk, Principal Investigator at Summit Research, explores how clinical research in dementias is evolving. From blood-based biomarkers and earlier diagnosis to innovative therapies and more accessible drug delivery, the field is shifting toward proactive, biologically driven care focused on preserving quality of life.

Read the full blog to learn more: https://headlandsresearch.com/blogs/clinical-research-in-dementias-progress-challenges-and-future-directions/

Address

Lake Worth, FL

Website

http://www.headlandsresearch.com/

Alerts

Be the first to know and let us send you an email when Headlands Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Lake Worth?